ResearcherFujian Medical UniversityNo recent work listed

Shuiliang Wang

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0002-5054-9064; OpenAlex author ID A5016058970.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Collaborators: 2

Papers, trials and grants by year

2019: 1 paper

Papers 1

Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting m… Last author DOI 10.1186/s13046-019-1160-9 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Weimin Zuo · 1 shared paper, 2019
- Paper Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via indu… DOI 10.1186/s13046-019-1160-9 ↗
Tingting Lin · 1 shared paper, 2019
- Paper Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via indu… DOI 10.1186/s13046-019-1160-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.